Breast Cancer New breast cancer drug may improve survival
LONDON - Arimidex, one of a new class of breast cancer drugs, has clearly beaten standard treatment tamoxifen at preventing breast cancer from returning in a 5-year study, researchers said on Wednesday.
Dr. Marcia Angell's case against drug companies and their business practices is tough, persuasive and troubling.